GHELARDONI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 5.880
EU - Europa 2.937
AS - Asia 958
AF - Africa 104
OC - Oceania 15
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.903
Nazione #
US - Stati Uniti d'America 5.692
IT - Italia 1.106
SE - Svezia 590
CN - Cina 535
BG - Bulgaria 280
DE - Germania 274
CA - Canada 187
UA - Ucraina 155
GB - Regno Unito 136
TR - Turchia 132
VN - Vietnam 104
FI - Finlandia 94
AT - Austria 85
CI - Costa d'Avorio 81
SG - Singapore 78
CH - Svizzera 66
IN - India 40
HK - Hong Kong 37
RU - Federazione Russa 37
FR - Francia 24
BE - Belgio 23
AU - Australia 15
GR - Grecia 13
SN - Senegal 13
JP - Giappone 12
NL - Olanda 11
PL - Polonia 10
NG - Nigeria 8
DK - Danimarca 7
AF - Afghanistan, Repubblica islamica di 6
ES - Italia 6
IR - Iran 6
CZ - Repubblica Ceca 5
KR - Corea 4
PT - Portogallo 4
EU - Europa 3
RO - Romania 3
BR - Brasile 2
CL - Cile 2
IE - Irlanda 2
PE - Perù 2
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 9.903
Città #
Woodbridge 974
Ann Arbor 661
Chandler 583
Houston 507
Milan 488
Fairfield 452
Ashburn 316
Sofia 280
Jacksonville 235
Wilmington 203
Beijing 178
Ottawa 177
New York 175
Cambridge 154
Seattle 152
Serra 146
Izmir 130
Princeton 127
Nanjing 123
Lawrence 109
Vienna 82
Abidjan 81
Medford 74
Dong Ket 67
Bern 65
Frankfurt am Main 56
Dearborn 53
Des Moines 51
Bremen 49
Redwood City 48
Jüchen 45
Florence 40
Rome 40
Hong Kong 33
Nanchang 33
Pisa 32
London 31
San Diego 30
Kunming 29
Boulder 28
Pune 25
Brussels 22
Falls Church 21
Lancaster 18
Los Angeles 16
Shenyang 16
Tianjin 16
Renton 15
Boardman 14
Changsha 14
Norwalk 14
Washington 14
Dakar 13
Hebei 13
Hefei 13
Singapore 13
Jiaxing 12
Ogden 11
Hangzhou 10
Orange 10
Guangzhou 9
Lagos 8
Chengdu 7
Guiyang 7
Hobart 6
Rødovre 6
Trezzo Sull'adda 6
Auburn Hills 5
Livorno 5
Melbourne 5
Saffron Walden 5
San Francisco 5
Santo Stefano D'aveto 5
Shanghai 5
Tappahannock 5
Warsaw 5
Bogen 4
Changchun 4
Chicago 4
Essen 4
Kent 4
Madison 4
Pietrasanta 4
Wuhan 4
Baleia 3
Berlin 3
Boston 3
Charleston 3
Costa Mesa 3
Düsseldorf 3
Montignoso 3
North York 3
Nürnberg 3
Phoenix 3
Prague 3
Roubaix 3
Shaoxing 3
Tokyo 3
Toronto 3
West Palm Beach 3
Totale 7.611
Nome #
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 161
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 152
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity 150
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 140
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 139
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 139
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 138
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 136
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 132
EFFECTS OF ALTERED GRAVITY ON STEM CELL BIOLOGY AND TISSUE REGENERATION IN THE PRESENCE OF CERIUM OXIDE NANOPARTICLES 131
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 131
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 130
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 130
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 128
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart 127
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 125
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 124
Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism 122
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 119
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 119
A new signalling pathway mediated by 3-iodothyronamine in rat heart 117
Characterization of 3-Iodothyronamine In Vitro Dynamics by Mathematical Modeling 117
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca2+ release in rat heart 116
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 116
A1 receptor stimulation induces changes in calcium homeostasis 115
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 115
Cardioprotective effect of growth hormone secretagogues in rat heart 115
Cardioprotection by ranolazine in perfused rat heart 114
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis 111
A1 adenosine receptor stimulates phospholamban expression 110
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 110
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 110
Cardioprotective effect of growth hormone secretagogues in rat heart 107
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 107
S-nitrosothiol detection in isolated perfused rat heart 105
3-iodothyronamine as a potential anti-tumor compound 105
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 104
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 102
Modulation of the cardiac sarcoplasmic reticulum release by adenosine: a protein kinase C-dependent pathway 101
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 101
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 101
Cardiac metabolism of 3-iodothyronamine 100
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 100
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 100
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart 100
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 99
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phospholamban expression 98
Cross-talk” between L-type sarcolemmal calcium channels and sarcoplasmic reticulum calcium release channels in rat myocardium 98
Cardiac effects of thyronamines 98
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phopsholamban expression 96
Cardiac Functional Effects of 3-Iodothyronamine, a New Endogenous Thyroid Hormone Derivative 96
Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat 96
Effect of 3-iodothyronamine on myocardial calcium homeostasis 91
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 90
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 90
Biochemical basis of ischemic heart injury and of cardioprotective interventions 90
T1AM A MASTER REGULATOR AND A POTENTIAL DRUG OF SIRTUIN PROTEINS: APPLICATIONS TO AGING AND CANCER 90
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 87
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 87
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 86
Ca2+-induced remodeling of Ca2+ channels in myocardium 85
Up-take of thyronines and 3-iodothyronamine in liver cells 85
Modulation of calcium channel expression in rat myocardium by work load 85
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion 85
New insights into 3-iodothyronamine (T1AM) cardiac metabolism by LC/MS/MS 84
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain 84
Ca2+ channel remodelling in perfused heart: effects of mechanical work and interventations affecting Ca2+ cycling on sarcolemmal and sarcoplasmic reticulum Ca2+ channels 84
3-iodothyronamine is a novel endogenous modulator of cardiac function 83
Cardioprotection and energy metabolism modulation by 3-iodothyronamine, a new endogenous chemical messanger 83
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 82
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 82
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum calcium release, 81
Chronic carbamazepine decreases the expression and the activity of cytosolic phospholipase A2 in rat brain 79
Uptake and metabolic effects of 3-iodothyronamine (T1AM) in hepatocytes 79
Short-term effects of pressure overload on the expression of genes involved in calcium homeostasis 78
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 77
Ghrelin tissue distribution: comparison between gene and protein expression 77
Detecting 3-iodothyronamine in the presence of fetal bovine serum: isotope kinetic effect and other pitfalls 76
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 76
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 75
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. 75
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 73
Modulation of cardiac ionic homeostasis by 3-iodothyronamine 73
Late preconditioning by adenosine is associated with reduced sarcoplasmic reticulum calcium uptake 71
Cardioprotection by A3 adenosine agonists: role of sarcoplasmic reticulum calcium release 71
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messanger 69
3-Iodothyronamine (T1AM), an endogenous fast acting thyroid hormone derivative: novel evidence for weight loss and glucose co-regulation by RNA gene expression 68
Melanin-concentrating hormone (MCH) neurons in the developing chick brain 65
Selective downregulation of brain cytosolic phospholipase A2 activity and protein in rats treated chronically with carbamazepine 64
Metabolic effects of 3-iodothyronamine in hepatocytes 64
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue 64
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 64
Effect of acute and chronic zofenopril administration on cardiac calcium homeostasis 61
Low dose 3-iodothyronamine increases acute lipolysis followed by protein catabolism in mouse 60
Modulation of L-type calcium channel expression by sarcoplasmic reticulum calcium release 60
Metabolome dynamics of T1AM, an endogenous thyroid hormone derivative: Effects on lipid metabolism, weight loss, and appetite in mice. 53
Resveratrol and catechin protect PC12 cells from beta-amyloid toxicity 50
Distribution of 3-iodothyronamine and trace amine-associated receptors in mouse 47
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells 46
Cardioprotective effect of ghrelin receptor stimulation 45
Totale 9.627
Categoria #
all - tutte 23.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019328 0 0 0 0 0 0 0 0 0 0 187 141
2019/20201.540 215 150 81 105 138 173 159 103 153 96 145 22
2020/2021799 86 22 71 46 101 61 56 74 60 51 38 133
2021/20221.136 17 83 23 56 220 160 29 46 53 51 90 308
2022/20231.732 223 243 130 191 189 224 8 107 283 8 94 32
2023/20241.373 218 198 186 128 241 245 43 41 30 27 16 0
Totale 10.048